BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 379227)

  • 1. Evaluation of group B streptococcal opsonins by radiolabeled bacterial uptake.
    Allred CD; Shigeoka AO; Hill HR
    J Immunol Methods; 1979; 26(4):355-63. PubMed ID: 379227
    [No Abstract]   [Full Text] [Related]  

  • 2. The loss of opsonic activity of bovine milk whey following depletion of IgA.
    Mackie DP; Meneely DJ; Pollock DA; Logan EF
    Vet Immunol Immunopathol; 1986 Feb; 11(2):193-8. PubMed ID: 3515746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonization of group B Streptococcus type III: studies using clinical strains and maternal sera.
    Hastings MJ; Neil J; Easmon CS
    Br J Exp Pathol; 1985 Jun; 66(3):317-23. PubMed ID: 3890914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods of assessment and importance of opsonic activity for GBS.
    Hill HR; Shigeoka AO; Rote NS; Allred CD; Hemming VG
    Antibiot Chemother (1971); 1985; 35():157-69. PubMed ID: 3901892
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-specific monoclonal antibody enhances the local phagocytic response to group B streptococcal infection.
    Shigeoka AO; Weber ME; Pincus SH; Pritchard DG; Egan ML; Hill HR
    J Infect Dis; 1986 Jun; 153(6):1170-3. PubMed ID: 3517190
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular and humoral aspects of host defense mechanisms against GBS.
    Gotoff SP; Boyer KM
    Antibiot Chemother (1971); 1985; 35():142-56. PubMed ID: 3901891
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenesis of neonatal group B streptococcal infections.
    Baltimore RS
    Yale J Biol Med; 1982; 55(3-4):291-5. PubMed ID: 6758375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-transfusion in group-B streptococcal sepsis.
    Shigeoka AO; Hall RT; Hill HR
    Lancet; 1978 Mar; 1(8065):636-8. PubMed ID: 76171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of complement in opsonization of GBS.
    Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
    Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunological aspects of group B streptococcal infections.
    Kretschmer RR; Gotoff SP
    Infection; 1978; 6(4):146-8. PubMed ID: 357294
    [No Abstract]   [Full Text] [Related]  

  • 12. Functional properties of anti-group B streptococcal monoclonal antibodies.
    Harris MC; Douglas SD; Kolski GB; Polin RA
    Clin Immunol Immunopathol; 1982 Sep; 24(3):342-50. PubMed ID: 6813008
    [No Abstract]   [Full Text] [Related]  

  • 13. Strain specificity of opsonins for group B streptococci types II and III.
    Shigeoka AO; Hall RT; Hill HR
    Infect Immun; 1979 Feb; 23(2):438-45. PubMed ID: 370017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody titer against B-streptococci in human gamma globulin].
    Fox EN; Schmidt BL; Collins MS
    MMW Munch Med Wochenschr; 1981 Nov; 123(46):1743-4. PubMed ID: 6171730
    [No Abstract]   [Full Text] [Related]  

  • 16. The opsonic activity of whey and sera from heifers experimentally infected with Streptococcus agalactiae.
    Mackie DP; Pollock DA; Logan EF
    Br Vet J; 1985; 141(4):349-54. PubMed ID: 3896387
    [No Abstract]   [Full Text] [Related]  

  • 17. Group-B streptococcus--profile of an organism.
    Ross PW
    J Med Microbiol; 1984 Oct; 18(2):139-66. PubMed ID: 6387125
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a universal Group B streptococcus vaccine by multiple genome screen.
    Maione D; Margarit I; Rinaudo CD; Masignani V; Mora M; Scarselli M; Tettelin H; Brettoni C; Iacobini ET; Rosini R; D'Agostino N; Miorin L; Buccato S; Mariani M; Galli G; Nogarotto R; Nardi-Dei V; Vegni F; Fraser C; Mancuso G; Teti G; Madoff LC; Paoletti LC; Rappuoli R; Kasper DL; Telford JL; Grandi G
    Science; 2005 Jul; 309(5731):148-50. PubMed ID: 15994562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoprecipitation and opsonic cross-reaction between type-14 pneumococcus and group-B streptococcus type III.
    Fischer GW; Lowell GH; Crumrine MH; Wilson SR
    Lancet; 1979 Jan; 1(8107):75-7. PubMed ID: 84130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein X of Streptococcus agalactiae induces opsonic antibodies in cows.
    Rainard P; Lautrou Y; Sarradin P; Poutrel B
    J Clin Microbiol; 1991 Sep; 29(9):1842-6. PubMed ID: 1774305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.